Stories Library

We proudly offer support and resources to researchers, healthcare providers, patients and their advocates as well as our local communities.

February 04, 2025

We Want More for Patients. A World Without Cancer.

By: Regeneron

On World Cancer Day, we’re motivated by the potential for more.

Research & Preclinical Development

A couple holding tennis rackets

October 01, 2024

Let’s Get Real About Skin Cancer

By: Andre Spring, Head of Global Oncology Marketing

Learn how Regeneron educates people on the risks of nonmelanoma skin cancers like BCC and CSCC and promotes early detection.

Research & Preclinical Development

Network graphic

August 29, 2024

Applying Emerging AI and Machine Learning Tools to Find Equitable Solutions to Scientific Discovery

By: Jeffrey Reid, Vice President, Chief Data Officer,
Regeneron Genetics Center®

Read about Applying Emerging AI and Machine Learning Tools to Find Equitable Solutions to Scientific Discovery

Research & Preclinical Development

Ear anatomy graphic

May 06, 2024

Hitting the “On Switch” in Hearing Loss

By: Regeneron

A novel gene therapy approach to genetic hearing loss

Clinical Research & Medicines, Research & Preclinical Development

Technical themed image of a test tube

January 25, 2023

More Genomics, Less Fear

By: Adolfo Ferrando, MD, PhD, Executive Director, Therapeutic Area Genetics, Oncology, Regeneron Genetics Center®

The genome is the how and why that define us

Genetics, Research & Preclinical Development

Scientist holding test tube

January 25, 2023

Más genómica, menos miedo

By: Adolfo Ferrando, MD, PhD, Executive Director, Therapeutic Area Genetics, Oncology, Regeneron Genetics Center®

El genoma es el cómo y el por qué que nos define

Genetics, Research & Preclinical Development

A graphic showing the impact of high LDL-C levels in the wall of a blood vessel.

June 01, 2022

It Takes a Village

By: Viktoria (Vika) Gusarova, PhD, Senior Director, Obesity, Metabolism & Muscle Diseases
Sergio Fazio, MD, PhD, Scientific Council Chair, Cardiometabolic Diseases

Research that led to important discoveries for the treatment of dangerously high cholesterol

Research & Preclinical Development

Bispecific antibodies

December 02, 2020

Two Targets May Be Better Than One

By: Israel Lowy, MD, PHD, Senior Vice President, Translational and Clinical Sciences, Oncology
Andres Sirulnik, MD, PHD, Senior Vice President, Translational and Clinical Sciences, Hematology

Regeneron leaders Andres Sirulnik and Israel Lowy discuss why they believe bispecific antibodies may be the next class of medicines to revolutionize cancer treatment.

Clinical Research & Medicines, Research & Preclinical Development

Drew Murphy, PhD, REGENERON Executive Vice President of Research, discussing antibodies

February 13, 2020

Pioneers In Antibody Medicine

By: Drew Murphy, PhD, Executive Vice President, Research

Antibodies have been at the heart of our research efforts for nearly thirty years, and some might say they are finally stepping into the limelight. See how antibodies are used as new and established medicines, including for infectious diseases.

Research & Preclinical Development

CD28 costimulatory bispecific antibodies

January 09, 2020

Tapping Preclinical Understanding For Smarter Trials

By: Dimitris Skokos, PhD, Senior Director, Cancer Immunology Research
Elizabeth Miller, Medical Director, Clinical Sciences, Global Development

The story behind Regeneron’s first costimulatory bispecific clinical trial

Research & Preclinical Development